Lateral Advancement Flap Versus Classic Limberg Flap in The Treatment Of NonComplicated Pilonidal Sinus
Lateral Advancement Adipo-Fascio-Cutaneous Flap Versus Classic Limberg Flap in The Treatment Of Non-Complicated Pilonidal Sinus: A Prospective Randomized Controlled Trial
1 other identifier
interventional
137
1 country
1
Brief Summary
Background The flaps closure including natal cleft obliteration and eccentric closure are becoming more popular due to their lower rate of recurrence including both the lateral advancement adipo-fascio-cutaneous flap and the classic limberg flap. Objective This study was aim to compare the results of the surgery for non-complicated pilonidal sinus with the lateral advancement adipo-fascio-cutaneous flap versus the classic Limberg flap. Patients and methods This study was a prospective randomized controlled, and was conducted on patients with non-complicated pilonidal sinus attending Zagazig University Hospitals, Egypt during the period from February 2017 to August 2019. Patients were randomly assigned to undergo either lateral advancement flap or classic Limberg flap groups. The follow-up period ranged from 12 to 36 months. Patient satisfaction, complications and recurrence rates were analyzed and compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2019
CompletedFirst Submitted
Initial submission to the registry
September 19, 2020
CompletedFirst Posted
Study publicly available on registry
October 1, 2020
CompletedOctober 1, 2020
September 1, 2020
2.6 years
September 19, 2020
September 26, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
recurrence
number of patients recurrence
12 - 36 months
Study Arms (2)
group A
ACTIVE COMPARATORPatients were randomly assigned to undergo lateral advancement flap
group B
ACTIVE COMPARATORPatients were randomly assigned to undergo classic Limberg flap
Interventions
Patients were randomly assigned to undergo either lateral advancement flap or classic Limberg flap for treatment of non-complicated pilonidal sinus
Patients were randomly assigned to undergo either lateral advancement flap or classic Limberg flap for treatment of non-complicated pilonidal sinus
Eligibility Criteria
You may qualify if:
- patients with non-complicated pilonidal sinus
- whose ages ranged from 18 to 60years
You may not qualify if:
- elderly patients with comorbid diseases
- scars from a previous pilonidal surgery or recurrent cases
- abscess presentations
- diabetes mellitus, immunodeficiency, or other co-morbidity
- American Society of Anesthesiologists physical status classification grade III-IV
- age \< 18years or \> 60 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zagazig University Hospitals
Zagazig, Sharqia Province, 44519, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
mohamed farid, MD
zagazig university hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate professor of general surgery
Study Record Dates
First Submitted
September 19, 2020
First Posted
October 1, 2020
Study Start
February 1, 2017
Primary Completion
August 31, 2019
Study Completion
August 31, 2019
Last Updated
October 1, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share
the Study Protocol and the Clinical Study Report are planned to be shared